Bualat, Baby Girl .

HRN: 21-99-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2022
AMPICILLIN 250MG (VIAL)
11/20/2022
11/26/2022
IVT
150mg
Q12
Neonatal Sepsis
Waiting Final Action 
11/20/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/20/2022
11/26/2022
IVT
20mg
OD
Neonatal Sepsis
Waiting Final Action 
11/20/2022
MUPIROCIN 2%, 15G (TUBE)
11/21/2022
11/28/2022
TOPICAL
-
BID
Phlebitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: